Upregulation of MMP-13 and TIMP-1 expression in response to mechanical strain in MC3T3-E1 osteoblastic cells
© Li et al; licensee BioMed Central Ltd. 2010
Received: 8 September 2010
Accepted: 17 November 2010
Published: 17 November 2010
Mechanical strain plays a significant role in the regulation of bone matrix turnover, which is mediated in part by matrix metalloproteinase (MMP)-13 and tissue inhibitors of matrix metalloproteinase (TIMP)-1. However, little is known about the correlation between mechanical strain and osteoblastic cell activities, including extracellular matrix (ECM) metabolism. Herein, we determined the effect of different magnitudes of cyclic tensile strain (0%, 6%, 12%, and 18%) on MMP-13 and TIMP-1 mRNA and protein expression in MC3T3-E1 osteoblasts. Furthermore, we employed specific inhibitors to examine the role of distinct signal transduction pathways known to mediate cellular responses to mechanical strain.
We identified a magnitude-dependent increase in MMP-13 and TIMP-1 mRNA and protein levels in response to mechanical strains corresponding to 6%, 12%, and 18% elongation. The strain-induced increases in MMP-13 and TIMP-1 mRNA expression were inhibited by PD098059 and cycloheximide, respectively.
Our results suggest a mechanism for the regulation of bone matrix metabolism mediated by the differential expression of MMP-13 and TIMP-1 in response to increasing magnitudes of mechanical strain.
Bone is continuously remodeled throughout life in order to meet the functional demands of its physiological and mechanical environment [1–3]. Furthermore, active remodeling of alveolar bone must occur in order to cope with orthodontic force and mechanical loading generated during orthodontic tooth movement. This remodeling process requires a complex turnover of the bone extracellular matrix, which is mediated in part by matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs)[4–7]. MMP-13, a member of the collagenase subgroup of MMP proteins, plays a key role in bone matrix degradation and is expressed highly in osteoblasts[3, 8–12]. MMP-13 is likely to contribute to bone healing[13, 14], bone development[15, 16], and bone loss. Previous studies also indicated that mRNA and protein levels of MMP-13 increase significantly following the application of orthodontic forces [18, 19]. In contrast, TIMP-1 is an endogenous inhibitor of bone matrix degradation that binds tightly to active MMP-13, thereby downregulating MMP-13 activity[20–22].
The cellular response to mechanical strain is regulated by the type, frequency, magnitude, and duration of the mechanical strain imposed. In response to mechanical loading of bone tissue, osteoblasts exhibit changes in enzymatic activity and in protein production. The effect of mechanical force on the expression of MMPs has been demonstrated using various cell types [23–26]. However, few reports have examined the correlation between varying magnitudes of mechanical strain and osteoblastic cell activities, including extracellular matrix (ECM) metabolism. The relationship between mechanical strain and the expression of MMP-13 and TIMP-1 in osteoblasts is not known, particularly with respect to increasing magnitudes of mechanical strain.
In this study, we investigated the effect of different magnitudes of mechanical strain on MMP-13 and TIMP-1 expression in osteoblasts. MC3T3-E1 osteoblastic cells were subjected to 0%, 6%, 12%, or 18% elongation using the Flexercell Strain Unit, followed semi-quantitative reverse transcriptase-PCR (RT-PCR) and immunoblot analysis to determine MMP-13 and TIMP-1 mRNA and protein expression levels, respectively. Finally, we used specific inhibitors to determine the signal transduction pathways that regulate MMP-13 and TIPM-1 upregulation in response to mechanical strain.
MC3T3-E1 cell culture
Mouse osteoblastic MC3T3-E1 cells were obtained from the Center Laboratory for Tissue Engineering, College of Stomatology, Fourth Military Medical University, Xi'an, China. MC3T3-E1 cells were maintained at 37°C in a humidified atmosphere of 5% CO2 in α-modified Eagle's minimum essential medium (α-MEM: Sigma, St. Louis, MO, USA) containing 10% fetal bovine serum (FBS; JRH Biosciences, Lenexa, KS, USA), 32 U/ml penicillin G (Meiji Seika, Tokyo, Japan), 250 μg/ml amphotericin B (Nacalai Tesque, Kyoto, Japan), and 60 μg/ml kanamycin (Meiji Seika, Tokyo, Japan). After reaching 90% confluency, the cells were detached by treatment with 10% trypsin-EDTA (Sigma) and cultured for 24 h on six-well, flexible-bottomed plates (type I collagen-coated, Flex I; Flexcell International, McKeesport, PA, USA) at a density of 2 × 105 cells/well; the 10% FBS-containing medium was replaced with 1% FBS-containing medium prior to the application of mechanical strain.
Application of strain force
Cells were plated onto six-well, flexible-bottomed plates at a density of 2 × 105 cells/well. After overnight incubation, the cells were nearly confluent and were subjected to mechanical strains of 6%, 12%, or 18% elongation at 6 cycles/min for 24 h using a Flexercell Strain Unit (FX 3000, Flexcell International), as described previously . Control cells (0% elongation) were cultured on similar plates and were maintained in the same incubator without mechanical strain.
Semi-quantitative RT-PCR was used to determine the effect of mechanical strain on MMP-13 and TIMP-1 mRNA expression levels. Total RNA was isolated using an RNeasy mini kit (Qiagen, Chatsworth, CA, USA), followed by reverse transcription using random hexamers to generate cDNA. The cDNA was amplified using PCR primer pairs for MMP-13, TIMP-1, or the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a control. The following primer sets were used [3, 4]: MMP-13 (445 bp RT-PCR product) sense 5'-GGTCCCAAACGAACTTAACTTACA-3', and MMP-13 antisense 5'-CCTTGAACGTCATCATCAGGAAGC- 3'; TIMP-1 (346 bp RT-PCR product) sense 5'-CCTTATACCAGCCGTTATAAGATCAAGAT-3', and TIMP-1 antisense 5'-GTCCACAAACAGTGAGTGTCACTC -3'; and GAPDH (983 bp RT-PCR product) sense 5'-GGTCGGTGTGAACGGATTTGG-3', and GAPDH antisense 5'-ATGTAGGCCATGAGGTCCACC-3'. PCR reactions for cDNA amplification included 2.5 mM dNTPs, 20 pmol/μl primers, and 5 U/μl Taq DNA polymerase. PCR amplification consisted of an initial denaturation step (94°C for 3 min), followed by thirty three-step cycles consisting of denaturation at 94°C for 30 s, annealing at a temperature optimized for each primer pair (MMP-13: 62°C, TIMP-1: 60°C, and GAPDH: 58°C) for 30 s, and extension at 72°C for 1 min; a final extension was carried out at 72°C for 10 min. The resulting PCR products were subjected to 2% agarose gel electrophoresis and were visualized by ethidium bromide staining. The relative intensities of the PCR products were measured using NIH Image software, and the results were normalized to the corresponding GAPDH mRNA levels.
Immunoblot analysis was performed using monoclonal antibodies against MMP-13 or TIMP-1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Total protein lysates were collected from cells, and the protein concentration was determined using the Bradford assay (Bio-Rad); BSA was used to generate the standard curve. Approximately 50 μg of total protein was loaded in each well of a 10% SDS PAGE gel; GAPDH served as the control for protein loading. Proteins were transferred electrophoretically onto nitrocellulose membranes (Hybond C, Amersham), followed by incubation in PBS-T buffer [PBS (pH 7.5) buffer containing 5% (w/v) blocking reagent (Amersham) and 1.0% (w/v) Tween 20 (Sigma, St. Louis, MO, USA)]. Individual membranes were incubated overnight in PBS-T buffer containing antibodies against MMP-13 or TIMP-1, followed by a 1 h incubation with goat anti-rabbit IgG conjugated to horseradish peroxidase (ECL Western blotting analysis system, Amersham). Protein bands corresponding to MMP-13, TIMP-1, and GAPDH were visualized, and the density of the protein bands was analyzed.
Enzyme-linked immunosorbent assay for the quantitative determination of active-MMP-13 and TIMP-1 concentrations
Conditioned media harvested from the cultured cells were used as samples. The concentrations of active form of MMP-13 and TIMP-1 in these supernatants were assayed using a comercially available enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Minneapolis, MN). Each sample was assayed in triplicate. For active-MMP-13 quantification, the samples and standards were quantified fluorometrically with a fluorescence plate reader (MFX Microtiter1 Plate Fluorometer, Dynex technologies, Chantilly, VA, USA) with excitation wavelength set to 320 nm and emission wavelength set to 405 nm. For TIMP-1 quantification, the samples and standards were quantified with a microplate reader (MRX Microplate reader, Dynex Technologies, Chantilly, VA, USA) capable of measuring absorbance at 450 nm, with the correction wavelength set at 540 nm. The concentrations of active form of MMP-13 and TIMP-1 were determined using a standard curve and normalized to the total cell number in each sample.
We used specific inhibitors to identify signal transduction pathways that mediate the cellular response to tensile stress. We employed cycloheximide (10 μM) to inhibit de novo protein synthesis, indomethacin (10 μM) to inhibit cyclooxygenase (COX), genistein (20 μM) to inhibit tyrosine kinase activity, and PD098059 (10 μM) to specifically inhibit extracellular signal-related kinase (ERK). All inhibitors were purchased from Sigma (St. Louis, MO, USA), and the concentrations used correspond to effective doses reported previously [5, 28]. MC3T3-E1 cells were pre-incubated in the presence of each inhibitor for 30 min, followed by the application of cyclic tensile strain at 18% elongation and 6 cycles/min in culture for 24 h. Total RNA was extracted from the cells, and MMP-13, TIMP-1, and GAPDH mRNA levels were determined by RT-PCR.
We performed these experiments using samples from at least five different cell preparations, and reproducibility was confirmed by using the same cell sample in triplicate. Values were calculated as means ± standard deviation (SD). Some data were subjected to multiple measurement analyses of variance (ANOVA), and a Student's t test was used to determine differences between the groups tested. P values of less than 0.05 were considered significant.
It has been demonstrated that matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) regulate matrix degradation. The balance between the activities of MMPs and TIMPs is believed to determine the rate of this process. Previous studies indicate that MMP-13 plays a key role in bone remodeling and mechanical strain can affect the expression of MMP-13 mRNA in osteoblasts. As we know the effects of mechanical strain on cells are dependent on the magnitude, duration, and frequency of mechanical strain, however, to date, very few reports have shown the effects of different magnitudes of mechanical strain on the mRNA and protein expression levels of MMP-13 and TIMP-1 in osteoblasts. The molecular biology mechanism of the regulation of extracellular matrix metabolism of osteoblasts under mechanical strain is not clear that progressive study should be carried out to clarify how different magnitudes of mechanical strain affect the expression of MMP-13 and TIMP-1 in osteoblasts. Yang et al.  reported previously that MMP-13 mRNA levels exhibited a time-dependent increase in MC3T3-E1 cells following the application of mechanical strain corresponding to 8% elongation. But, the correlation between varying magnitudes of mechanical strain and the expression of MMP-13 in osteoblasts is not known. The present study demonstrates that MC3T3-E1 cells subjected to 6%, 12%, or 18% elongation exhibit a magnitude-dependent increase in MMP-13 mRNA and protein levels (See figure 1). Active-MMP-13 concentration in conditioned medium induced by mechanical strain in MC3T3-E1 cells also increased significantly in a magnitude-dependent manner compared to that in the control (See figure 3). Several lines of evidence suggest that low levels of mechanical strain (1.8% - 6% elongation) generate potent anti-inflammatory signals, whereas high levels of mechanical strain (12% - 18% elongation) generate an inflammatory signal and induce PGE2 and IL-1β, both implicated in matrix degradation[29–32]. In the present study, we found that the increase in MMP-13 expression was magnitude-dependent. Furthermore, mechanical strain corresponding to 6%, 12%, or 18% elongation led to a magnitude-dependent increase in TIMP-1 mRNA and protein expression (See figure 2). TIMP-1 concentration in conditioned medium induced by 12%, or 18% elongation mechanical strain increased significantly compared to that in the control (See figure 3). Collectively, these results suggest that the increase in MMP-13 levels observed in osteoblastic cells under mechanical strain levels higher than those found under normal physiological conditions is accompanied by a corresponding increase in TIMP-1. TIMP-1 may in turn bind to activated MMP-13, thereby inhibiting MMP-13 activity and suppressing the degradation of bone matrix as part of the body's defense system. Our present findings may help to explain the lack of pathological inflammatory changes during orthodontic tooth movement when mechanical strain loads the alveolar bone. It appears that the essential functions of osteoblasts in bone remodeling are affected by the magnitude of mechanical strain and that cellular responses to mechanical strain are crucial to maintaining homeostasis and adapting to the bone environment.
The molecular mechanisms translating mechanical strain into a signal that activates increased gene expression are complicated. Mechanotransduction pathways may initiate signal transduction through many possible mechanisms including integrins, receptor tyrosine kinases, ion channel, gap junction, membrane fluidity, etc. To determine whether the stretch-induced increases in MMP-13 and TIMP-1 mRNA expression were dependent on de novo protein synthesis, cyclooxygenase activity, tyrosine kinase activity, or extracellular signal-related kinase activity, MC3T3-E1 cells were treated with specific inhibitors, including cycloheximide, indomethacin, genistein, or PD098059, respectively. We found that only the MEK inhibitor PD098059 was capable of blocking the strain-induced upregulation of MMP-13 mRNA (See figure 4). This result indicates that MMP-13 induction is mediated by signaling molecules related to extracellular signal-regulated kinase (ERK), which is supported by a previous study. Therefore, the ERK-MAPK pathway is likely to contribute to the strain-induced increase in MMP-13 mRNA expression. In contrast, the signaling pathway linked to the induction of TIMP-1 mRNA expression was blocked by cycloheximide (See figure 5), indicating that strain-induced up-regulation of TIMP-1 mRNA required de novo protein synthesis, and suggesting that the strain-induced upregulation of TIMP-1 mRNA is not the primary response; rather, TIMP-1 upregulation required the synthesis of an as yet unidentified protein(s).
In conclusion, the application of different magnitudes of cyclic tensile strain (0%, 6%, 12%, or 18%) induced a magnitude-dependent increase in MMP-13 and TIMP-1 expression in cultured osteoblasts. Furthermore, we provide evidence that PD098059 and cyclohexamide treatment suppressed the strain-induced upregulation of MMP-13 and TIMP-1 expression, respectively. These results indicate that MMP-13 and TIMP-1 expression are differentially regulated in response to increasing magnitudes of mechanical strain in osteoblasts. This effect may regulate bone matrix metabolism, and suggests novel mechanisms through which osteoblasts may respond and adapt to mechanical strain, including occlusal and orthodontic forces, in order to maintain homeostasis and adapt to the bone environment.
This study was supported by grants from the National Natural Science Foundation of China (No.30570455 and No.30970697).
- Duncan RL, Turner CH: Mechanotransduction and the functional response of bone to mechanical strain. Calcif Tissue Int. 1995, 57: 344-358. 10.1007/BF00302070.PubMedView ArticleGoogle Scholar
- Umemura Y, Baylink DJ, Wergedal JE, Mohan S, Srivastava AK: A time course of bone response to jump exercise in C57BL/6J mice. J Bone Miner Metab. 2002, 20: 209-215. 10.1007/s007740200030.PubMedView ArticleGoogle Scholar
- Yang CM, Chien CS, Yao CC, Hsiao LD, Huang YC, Wu CB: Mechanical strain induces collagenase-3 (MMP-13) expression in MC3T3-E1 osteoblastic cells. J Biol Chem. 2004, 279: 22158-22165. 10.1074/jbc.M401343200.PubMedView ArticleGoogle Scholar
- Uchida M, Shima M, Shimoaka T, Fujieda A, Obara K, Suzuki H, Nagai Y, Ikeda T, Yamato H, Kawaguchi H: Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells. J Cell Physiol. 2000, 185: 207-214. 10.1002/1097-4652(200011)185:2<207::AID-JCP5>3.0.CO;2-J.PubMedView ArticleGoogle Scholar
- Onodera S, Nishihira J, Iwabuchi K, Koyama Y, Yoshida K, Tanaka S, Minami A: Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts, Relevance to intracellular signaling pathways. J Biol Chem. 2002, 277: 7865-7874. 10.1074/jbc.M106020200.PubMedView ArticleGoogle Scholar
- Naka T, Boltze C, Kuester D, Schulz TO, Samii A, Herold C, Ostertag H, Roessner A: Expression of matrix metalloproteinase (MMP)-1, MMP-2, MMP-9, cathepsin B, and urokinase plasminogen activator in nonskull base chordoma. Am J Clin Pathol. 2004, 122: 926-930. 10.1309/C8T7APJDAUPR8TLL.PubMedView ArticleGoogle Scholar
- Nakashima A, Tamura M: Regulation of matrix metalloproteinase-13 and tissue inhibitor of matrix metalloproteinase-1 gene expression by WNT3A and bone morphogenetic protein-2 in osteoblastic differentiation. Front Biosci. 2006, 11: 1667-1678. 10.2741/1912.PubMedView ArticleGoogle Scholar
- Stahle-Backdahl M, Sandstedt B, Bruce K, Lindahl A, Jimenez MG, Vega J A, Lopez-Otin C: Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab Invest. 1997, 76: 717-728.PubMedGoogle Scholar
- Tuckermann JP, Pittois K, Partridge NC, Merregaert J, Angel P: Collagenase-3 (MMP-13) and integral membrane protein 2a (Itm2a) are marker genes of chondrogenic/osteoblastic cells in bone formation: sequential temporal, and spatial expression of Itm2a, alkaline phosphatase, MMP-13, and osteocalcin in the mouse. J Bone Miner Res. 2000, 15: 1257-1265. 10.1359/jbmr.2000.15.7.1257.PubMedView ArticleGoogle Scholar
- Fratzl-Zelman N, Glantschnig H, Rumpler M, Nader A, Ellinger A, Varga F: The expression of matrix metalloproteinase-13 and osteocalcin in mouse osteoblasts is related to osteoblastic differentiation and is modulated by 1,25-dihydroxyvitamin D3 and thyroid hormones. Cell Biol Int. 2003, 27: 459-468. 10.1016/S1065-6995(03)00037-4.PubMedView ArticleGoogle Scholar
- Li J, Liao EY, Dai RC, Wei QY, Luo XH: Effects of 17 beta-estradiol on the expression of interstitial collagenases-8 and -13 (MMP-8 and MMP-13) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in ovariectomized rat osteoblastic cells. J Mol Histol. 2004, 35: 723-731. 10.1007/s10735-004-6206-3.PubMedView ArticleGoogle Scholar
- Zaragoza C, López-Rivera E, García-Rama C, Saura M, Martínez-Ruíz A, Lizarbe TR: Martín-de-Lara F, Lamas S. Cbfa-1 mediates nitric oxide regulation of MMP-13 in osteoblasts. J Cell Sci. 2006, 119: 1896-1902. 10.1242/jcs.02895.PubMedView ArticleGoogle Scholar
- Yamagiwa H, Tokunaga K, Hayami T, Hatano H, Uchida M, Endo N, Takahashi HE: Expression of metalloproteinase-13 (Collagenase-3) is induced during fracture healing in mice. Bone. 1999, 25: 197-203. 10.1016/S8756-3282(99)00157-X.PubMedView ArticleGoogle Scholar
- Henle P, Zimmermann G, Weiss S: Matrix metalloproteinases and failed fracture healing. Bone. 2005, 37: 791-798. 10.1016/j.bone.2005.06.015.PubMedView ArticleGoogle Scholar
- Inada M, Wang Y, Byrne MH, Rahman MU, Miyaura C, Lopez-Otin C, Krane SM: Critical roles for collagenase-3 (MMP-13) in development of growth plate cartilage and in endochondral ossification. P Natl Acad Sci USA. 2004, 101: 17192-17197. 10.1073/pnas.0407788101.View ArticleGoogle Scholar
- Stickens D, Behonick DJ, Ortega N, Heyer B, Hartenstein B, Yu Y, Fosang AJ, Schorpp-Kistner M, Angel P, Werb Z: Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development. 2004, 131: 5883-5895. 10.1242/dev.01461.PubMed CentralPubMedView ArticleGoogle Scholar
- Pelletier JP, Boileau C, Brunet J, Boily M, Lajeunesse D, Reboul P, Laufer S, Martel-Pelletier J: The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K. Bone. 2004, 34: 527-538. 10.1016/j.bone.2003.11.021.PubMedView ArticleGoogle Scholar
- Takahashi I, Nishimura M, Onodera K, Bae JW, Mitani H, Okazaki M: Expression of MMP-8 and MMP-13 genes in the periodontal ligament during tooth movement in rats. J Dent Res. 2003, 82: 646-651. 10.1177/154405910308200815.PubMedView ArticleGoogle Scholar
- Leonardi R, Talic NF, Loreto C: MMP-13 (collagenase 3) immunolocalisation during initial orthodontic tooth movement in rats. Acta histochemica. 2007, 109: 215-220. 10.1016/j.acthis.2007.01.002.PubMedView ArticleGoogle Scholar
- Olson MW, Gervasi DC, Mobashery S, Fridman R: Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J Biol Chem. 1997, 272: 29975-29983. 10.1074/jbc.272.47.29975.PubMedView ArticleGoogle Scholar
- Dzwonek J, Rylski M, Kaczmarek L: Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett. 2004, 567: 129-135. 10.1016/j.febslet.2004.03.070.PubMedView ArticleGoogle Scholar
- Lambert E, Dasse E, Haye B, Petitfrere E: TIMPs as multifacial proteins. Crit Rev Oncol Hemat. 2004, 49: 187-198. 10.1016/j.critrevonc.2003.09.008.View ArticleGoogle Scholar
- Sun HB, Yokota H: Reduction of cytokine-induced expression and activity of MMP-1 and MMP-13 by mechanical strain in MH7A rheumatoid synovial cells. Matrix Biol. 2002, 21: 263-270. 10.1016/S0945-053X(02)00003-3.PubMedView ArticleGoogle Scholar
- Collins JM, Ramamoorthy K, Silveria AD, Patston P, Mao JJ: Expression of matrix metalloproteinase genes in the rat intramembranous bone during postnatal growth and upon mechanical stresses. J Biomech. 2005, 38: 485-492. 10.1016/j.jbiomech.2004.04.018.PubMedView ArticleGoogle Scholar
- He Y, Macarak EJ, Korostoff JM, Howa PS: Compression and tension: differential effects on matrix accumulation by periodontal ligament fibroblasts in vitro. Connect Tissue Res. 2004, 45: 28-39. 10.1080/03008200490278124.PubMedView ArticleGoogle Scholar
- Shelton L, Rada JS: Effects of cyclic mechanical stretch on extracellular matrix synthesis by human scleral fibroblasts. Exp Eye Res. 2007, 84: 314-322. 10.1016/j.exer.2006.10.004.PubMed CentralPubMedView ArticleGoogle Scholar
- Tang L, Lin Z, Li YM: Effects of different magnitudes of mechanical strain on osteoblasts in vitro. Biochem Biophys Res Commun. 2006, 344: 122-128. 10.1016/j.bbrc.2006.03.123.PubMedView ArticleGoogle Scholar
- Kletsas D, Basdra EK, Papavassiliou AG: Effect of protein kinase inhibitors on the stretch-elicited c-Fos and c-Jun upregulation in human PDL osteoblast-like cells. J Cell Physiol. 2002, 190: 313-321. 10.1002/jcp.10052.PubMedView ArticleGoogle Scholar
- Saito S, Rosol TJ, Ngan P, Shanfeld J, Davidovitch Z: Bone resorbingactivity of prostaglandin E produced by human periodontal ligament cells in vitro. J Bone Miner Res. 1990, 5: 1013-1018. 10.1002/jbmr.5650051004.PubMedView ArticleGoogle Scholar
- Fermor B, Gundle R, Evans M, Emerton M, Pocock A, Murray D: Primary human osteoblast proliferation and prostaglandin E2 release in response to mechanical strain in vitro. Bone. 1998, 22: 637-643. 10.1016/S8756-3282(98)00047-7.PubMedView ArticleGoogle Scholar
- Shimizu N, Ozawa Y, Yamaguchi M, Goseki T, Ohzeki K, Abiko Y: Induction of COX-2 expression by mechanical tension force in human periodontal ligament cells. J Periodontol. 1998, 69: 670-677.PubMedView ArticleGoogle Scholar
- Long P, Liu F, Piesco NP, Kapur R, Agarwal S: Signaling by mechanical strain involves transcriptional regulation of proinflammatory genes in human periodontal ligament cells in vitro. Bone. 2002, 30: 547-552. 10.1016/S8756-3282(02)00673-7.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.